Forty-eighth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. 00:00 Introduction 01:00 Blood biomarkers predicted cognition 6 and 12 months post COVID 03:00 MERS-CoV cases 05:00...
The XBB.1.5 subvariant, known informally as “Kraken”, is the latest in a menagerie of Omicron subvariants to dominate the headlines, following increasing detection in the United States and United Kingdom. But there have...
Vaccine hesitancy about COVID-19 vaccines is a positive predictor of negative side effects with vaccination—an example of the “nocebo” effect—according to a study in Scientific Reports. Nocebo, a play on...
The COVID pandemic showed lack of preparedness in many public health areas all over Europe. One such gap – often overlooked – is the lack of tools to rapidly conduct clinical studies on new vaccines. This gap has...
Omicron is very good at evading the immune protection conferred by vaccines, natural infection and agents such as monoclonal antibodies (mAbs) authorized to prevent serious infections, according to David Ho, MD, the...
A recent study by Johns Hopkins Medicine researchers provides evidence that CD4+ T lymphocytes — immune system cells also known as helper T cells — produced by people who received either of the two available messenger...
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries. A new type of...
With ATAGI flagging that third doses and booster shots could soon be used to further protect against COVID, newsGP assesses preliminary results from Moderna and Pfizer’s ongoing clinical trials. Questions regarding...
The Pfizer–BioNTech and Oxford–AstraZeneca COVID-19 vaccines are effective against the highly infectious Delta variant of SARS-CoV-2 — but their protection drops away over time, a study of infections in the United...
Scientists in the United Kingdom reported that a small number of B117 variants have developed the E484K mutation thought to help SARS-CoV-2 partly evade immunity, and another UK group said their lab experiments suggest...